| 发明名称 |
GLP-1 fusion proteins |
| 摘要 |
The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.
|
| 申请公布号 |
US7271149(B2) |
申请公布日期 |
2007.09.18 |
| 申请号 |
US20030433108 |
申请日期 |
2003.05.29 |
| 申请人 |
ELI LILLY AND COMPANY |
发明人 |
GLAESNER WOLFGANG;MICANOVIC RADMILA;TSCHANG SHENG-HUNG RAINBOW |
| 分类号 |
A61K38/26;C12N15/02;A61K38/00;A61P3/04;A61P3/10;C07H21/04;C07K14/605;C07K14/76;C07K14/765;C07K16/18;C07K19/00;C12N5/10;C12N15/62;C12P21/02 |
主分类号 |
A61K38/26 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
